NCT04422028View on ClinicalTrials.gov

Bioavailability of Desogestrel 0.075 mg Tablets With Regards to Reference Product

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 11, 2020

Primary Completion Date

January 11, 2020

Study Completion Date

January 28, 2020

Conditions
Bioequivalence
Interventions
DRUG

Desogestrel 0.075 MG

Test Drug

DRUG

Desogestrel 0.075 MG

Reference Product

Trial Locations (1)

Unknown

Innolab, Santiago

Sponsors
All Listed Sponsors
lead

Laboratorios Andromaco S.A.

INDUSTRY

NCT04422028 - Bioavailability of Desogestrel 0.075 mg Tablets With Regards to Reference Product | Biotech Hunter | Biotech Hunter